Delivery Order SPE2DB24D2100-SPE2DB25FBBYV
Award Date
1/31/25
Potential Completion Date
2/24/25
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IBRANCE 100 MG CAPSULE 21S, a pharmaceutical product. The contract has a firm fixed price of $8,122.48 and a completion date of July 25, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,796.30, is for the delivery of IBRANCE 100 MG CAPSULE 21S, a pharmaceutical product, with a period of performance through March 26, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999...
This is a $16,244.96 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IBRANCE 100 MG CAPSULE 21S, a pharmaceutical product, with a period of performance through June 9, 2025. The contract is a firm-fixed-price type, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of IBRANCE 125 MG CAPSULE 21S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $16,236.16 and a period of performance through June 4, 2025. The contract is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of IBRANCE 125 MG CAPSULE 21S medication. The $8,118.08 firm fixed-price contract has a completion date of July 10, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
This is a firm-fixed price delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IBRANCE 100 MG CAPSULE 21S, with a ceiling value of $8,122.48 and a completion date of June 12, 2025. The award was made on May 21, 2025, and the contract is not set aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,065.75 firm fixed-price delivery order is for the supply of IBRANCE 100 MG CAPSULE 21S, a pharmaceutical product, with a period of performance through February 12, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,118.08 firm fixed-price contract is for the delivery of IBRANCE 125 MG CAPSULE 21S, a prescription medication. The award has an ultimate completion date of July 14, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any major subcontractors. This award is not set aside and is...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IBRANCE 125 MG CAPSULE 21S, a pharmaceutical product, with a ceiling value of $8,118.08 and a period of performance through July 17, 2025. The contract is designated as a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition....
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $7,792.08, is for the supply of the pharmaceutical product Ibrance 125 mg Capsule 21s. The award has an ultimate completion date of October 31, 2024 and is a firm fixed-price contract. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by various defense and civilian agencies to provide a...